Psychedelic Biotech Company Lusaris Therapeutics Launching $60 Million Series A Financing Nov 3, 2022
Numinus CEO Payton Nyquvest On Alberta Becoming First Canadian Province To Regulate Psychedelic Drugs Oct 31, 2022